Skip to main content

Advertisement

SpringerLink
Log in

Topical glucocorticoid or pimecrolimus treatment suppresses thymic stromal lymphopoietin-related allergic inflammatory mechanism in an oxazolone-induced atopic dermatitis murine model

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Congenitally or early impaired skin barrier as the first event starting the ‘atopic march’ in atopic dermatitis (AD) patients can increase allergen penetration that results in sensitization, even in the airways, followed by asthma and allergic rhinitis. Thymic stromal lymphopoietin (TSLP) is a cytokine existing in high levels in AD skin and is considered as a novel therapeutic target for atopic disease. We generated oxazolone (Ox)-induced AD-like (Ox-AD) hairless mice and divided them into four groups according to the therapeutic challenges: topical glucocorticoid, pimecrolimus, emollient, and control (acetone-only treated). We assessed the functional studies of skin barrier, epidermal expressions of differentiation markers, IL-1α, TNF-α, proteinase-activated receptor-2 (PAR-2), TSLP and antimicrobial peptides (AMP), and serum IgE in each group. Topical glucocorticoid or pimecrolimus treatment improved AD-like skin lesions and barrier functions, and restored the epidermal expression of differentiation markers, IL-1α, TNF-α, PAR-2, and TSLP, in Ox-AD mice. The improvement was relatively better with the glucocorticoid than pimecrolimus. Epidermal AMP expression was restored by topical glucocorticoid, but not pimecrolimus. Our result showed that topical glucocorticoid or pimecrolimus improved the AD-like skin lesions and barrier impairment by suppressing TSLP-related allergic inflammation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Aberg KM, Man MQ, Gallo RL, Ganz T, Crumrine D, Brown BE, Choi EH, Kim DK, Schroder JM, Feingold KR, Elias PM (2008) Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers. J Invest Dermatol 128:917–925

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Allakhverdi Z, Comeau MR, Jessup HK, Yoon BR, Brewer A, Chartier S, Paquette N, Ziegler SF, Sarfati M, Delespesse G (2007) Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med 204:253–258

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Bergmann RL, Wahn U, Bergmann KE (1997) The allergy march: from food to pollen. Environ Toxicol Pharmacol 4:79–83

    Article  CAS  PubMed  Google Scholar 

  4. Briot A, Deraison C, Lacroix M, Bonnart C, Robin A, Besson C, Dubus P, Hovnanian A (2009) Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J Exp Med 206:1135–1147

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Briot A, Lacroix M, Robin A, Steinhoff M, Deraison C, Hovnanian A (2010) Par2 inactivation inhibits early production of TSLP, but not cutaneous inflammation, in Netherton syndrome adult mouse model. J Invest Dermatol 130:2736–2742

    Article  CAS  PubMed  Google Scholar 

  6. Cocks TM, Fong B, Chow JM, Anderson GP, Frauman AG, Goldie RG, Henry PJ, Carr MJ, Hamilton J, Moffatt JD (1999) A protective role for protease activated receptors in the airways. Nature 398:156–160

    Article  CAS  PubMed  Google Scholar 

  7. Cork MJ, Danby SG, Vasilopoulos Y, Hadgraft J, Lane ME, Moustafa M, Guy RH, Macgowan AL, Tazi-Ahnini R, Ward SJ (2009) Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol 129:1892–1908

    Article  CAS  PubMed  Google Scholar 

  8. Demehri S, Morimoto M, Holtzman MJ, Kopan R (2009) Skin-derived TSLP triggers progression from epidermal-barrier defects to asthma. PLoS Biol 7:e1000067

    Article  PubMed Central  PubMed  Google Scholar 

  9. Demehri S, Liu Z, Lee J et al (2008) Notch-deficient skin induces a lethal systemic B-lymphoproliferative disorder by secreting TSLP, a sentinel for epidermal integrity. PLoS Biol 6:e123

    Article  PubMed Central  PubMed  Google Scholar 

  10. Dumortier A, Durham AD (2010) Di Piazza M (2010) Atopic dermatitis-like disease and associated lethal myeloproliferative disorder arise from loss of Notch signaling in the murine skin. PLoS One 5:e9258

    Article  PubMed Central  PubMed  Google Scholar 

  11. Ebner S, Nguyen VA, Forstner M, Wang YH, Wolfram D, Liu YJ, Romani N (2007) Thymic stromal lymphopoietin converts human epidermal Langerhans cells into antigen-presenting cells that induce proallergic T cells. J Allergy Clin Immunol 119:982–990

    Article  CAS  PubMed  Google Scholar 

  12. El-Batawy MM, Bosseila MA, Mashaly HM, Hafez VS (2009) Topical calcineurin inhibitors in atopic dermatitis: a systematic review and meta-analysis. J Dermatol Sci 54:76–87

    Article  CAS  PubMed  Google Scholar 

  13. Fehervari Z (2012) TSLP underlies the atopic march. Nat Immunol 13:533

    Google Scholar 

  14. Franzke CW, Cobzaru C, Triantafyllopoulou A et al (2012) Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation. J Exp Med 209:1105–1119

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Han H, Xu W, Headley MB, Jessup HK, Lee KS, Omori M, Comeau MR, Marshak-Rothstein A, Ziegler SF (2012) Thymic stromal lymphopoietin (TSLP)-mediated dermal inflammation aggravates experimental asthma. Mucosal Immunol 5:342–351

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Hatano Y, Elias PM, Crumrine D, Feingold KR, Katagiri K, Fujiwara S (2011) Efficacy of combined peroxisome proliferator-activated receptor-alpha ligand and glucocorticoid therapy in a murine model of atopic dermatitis. J Invest Dermatol 131:1845–1852

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. He R, Oyoshi MK, Garibyan L, Kumar L, Ziegler SF, Geha RS (2008) TSLP acts on infiltrating effector T cells to drive allergic skin inflammation. Proc Natl Acad Sci USA 105:11875–11880

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Jenerowicz D, Czarnecka-Operacz M, Silny W (2005) Corticosteroid phobia in patients with atopic dermatitis. Wiad Lek 58:607–615

    PubMed  Google Scholar 

  19. Jung YJ, Jung M, Kim M, Hong SP, Choi EH (2011) IL-1alpha stimulation restores epidermal permeability and antimicrobial barriers compromised by topical tacrolimus. J Invest Dermatol 131:698–705

    Article  CAS  PubMed  Google Scholar 

  20. Kouzaki H, O’Grady SM, Lawrence CB, Kita H (2009) Proteases induce production of thymic stromal lymphopoietin by airway epithelial cells through protease-activated receptor-2. J Immunol 183:1427–1434

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  21. Lee EB, Kim KW, Hong JY, Jee HM, Sohn MH, Kim KE (2010) Increased serum thymic stromal lymphopoietin in children with atopic dermatitis. Pediatr Allergy Immunol 21:e457–e460

    Article  PubMed  Google Scholar 

  22. Lee HJ, Jung M, Kim JH, Yoon NY, Choi EH (2012) The effect of adipose-derived stem cell-cultured media on oxazolone treated atopic dermatitis-like murine model. Ann Dermatol 24:181–188

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Le TA, Takai T, Kinoshita H, Suto H, Ikeda S, Okumura K, Ogawa H (2009) Inhibition of double-stranded RNA-induced TSLP in human keratinocytes by glucocorticoids. Allergy 64:1231–1232

    Article  CAS  PubMed  Google Scholar 

  24. Le TA, Takai T, Vu AT, Kinoshita H, Ikeda S, Ogawa H, Okumura K (2010) Glucocorticoids inhibit double-stranded RNA-induced thymic stromal lymphopoietin release from keratinocytes in an atopic cytokine milieu more effectively than tacrolimus. Int Arch Allergy Immunol 153:27–34

    Article  CAS  PubMed  Google Scholar 

  25. Li M, Hener P, Zhang Z, Kato S, Metzger D, Chambon P (2006) Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis. Proc Natl Acad Sci USA 103:11736–11741

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Lin HY, Kao CH, Lin KM, Kaartinen V, Yang LT (2011) Notch signaling regulates late-stage epidermal differentiation and maintains postnatal hair cycle homeostasis. PLoS One 6:e15842

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Liu H, Pan JH, Lou WL, He JG (2010) Effects of inhaled budesonide on the bronchial-pulmonary pathology and expression of thymic stromal lymphopoietin in lung tissues in asthmatic rats. Zhongguo Dang Dai Er Ke Za Zhi 12:816–819

    CAS  PubMed  Google Scholar 

  28. Liu YJ (2006) Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med 203:269–273

    Article  PubMed Central  PubMed  Google Scholar 

  29. Man MQ, Hatano Y, Lee SH, Man M, Chang S, Feingold KR, Leung DY, Holleran W, Uchida Y, Elias PM (2008) Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges. J Invest Dermatol 128:79–86

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  30. Meingassner JG, Fahrngruber H, Bavandi A (2003) Pimecrolimus inhibits the elicitation phase but does not suppress the sensitization phase in murine contact hypersensitivity, in contrast to tacrolimus and cyclosporine A. J Invest Dermatol 121:77–80

    Article  CAS  PubMed  Google Scholar 

  31. Melnik BC (2014) Does therapeutic intervention in atopic dermatitis normalize epidermal Notch deficiency? Exp Dermatol 23:696–700

    Article  CAS  PubMed  Google Scholar 

  32. Melnik BC (2014) The potential role of impaired Notch signalling in atopic dermatitis. Acta Derm Venereol May [Epub ahead of print]

  33. Murthy A, Shao YW, Narala S et al (2012) Notch activation by the metalloproteinase ADAM17 regulates myeloproliferation and atopic barrier immunity by suppressing epithelial cytokine synthesis. Immunity 36:105–119

    Article  CAS  PubMed  Google Scholar 

  34. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347:1151–1160

    Article  CAS  PubMed  Google Scholar 

  35. Ozawa T, Koyama K, Ando T, Ohnuma Y, Hatsushika K, Ohba T, Sugiyama H, Hamada Y, Ogawa H, Okumura K, Nakao A (2007) Thymic stromal lymphopoietin secretion of synovial fibroblasts is positively and negatively regulated by Toll-like receptors/nuclear factor-kappaB pathway and interferon-gamma/dexamethasone. Mod Rheumatol 17:459–463

    Article  CAS  PubMed  Google Scholar 

  36. Palatsi R, Hagg P (2011) The immune response against microbial infections in the skin–weak in atopic dermatitis and strong in psoriasis. Duodecim 127:127–134

    PubMed  Google Scholar 

  37. Patrizi A, Pileri A, Bellini F, Raone B, Neri I, Ricci G (2011) Atopic dermatitis and the atopic march: what is new? J Allergy (Cairo) 2011:279425

    Google Scholar 

  38. Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, Gilliet M, Ho S, Antonenko S, Lauerma A, Smith K, Gorman D, Zurawski S, Abrams J, Menon S, McClanahan T, de Waal-Malefyt RdR, Bazan F, Kastelein RA, Liu YJ (2002) Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3:673–680

    Article  CAS  PubMed  Google Scholar 

  39. Spergel JM, Paller AS (2003) Atopic dermatitis and the atopic march. J Allergy Clin Immunol 112:S118–S127

    Article  PubMed  Google Scholar 

  40. Weber S, Niessen MT, Prox J et al (2011) The disintegrin/metalloproteinase Adam10 is essential for epidermal integrity and notch-mediated signaling. Development 138:495–505

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  41. Wood LC, Jackson SM, Elias PM, Grunfeld C, Feingold KR (1992) Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 90:482–487

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  42. Zhang Y, Zhou X, Zhou B (2012) DC-derived TSLP promotes Th2 polarization in LPS-primed allergic airway inflammation. Eur J Immunol 42:1735–1743

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  43. Ziegler SF, Artis D (2010) Sensing the outside world: TSLP regulates barrier immunity. Nat Immunol 11:289–293

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by a grant of the National Research Foundation of Korea (2012R1A1A4A01013614).

Conflict of interest

There is no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Dermatology, Yonsei University Wonju College of Medicine, 20 Ilsan-ro, Wonju, Republic of Korea

    Na Young Yoon, Min young Jung, Dong Hye Kim, Hae Jin Lee & Eung Ho Choi

Authors
  1. Na Young Yoon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Min young Jung
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dong Hye Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hae Jin Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Eung Ho Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eung Ho Choi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yoon, N.Y., Jung, M.y., Kim, D.H. et al. Topical glucocorticoid or pimecrolimus treatment suppresses thymic stromal lymphopoietin-related allergic inflammatory mechanism in an oxazolone-induced atopic dermatitis murine model. Arch Dermatol Res 307, 569–581 (2015). https://doi.org/10.1007/s00403-015-1558-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-015-1558-y

Keywords

Search

Navigation